MedPath

Project INSPIRE: INtervention Support Groups: Peers Inspiring Resilience and Empowerment

Not Applicable
Terminated
Conditions
Domestic Violence
Interventions
Behavioral: Traditional Domestic Violence Support Group
Registration Number
NCT05826041
Lead Sponsor
Yale University
Brief Summary

The investigators will develop a new, integrated, group intervention to enhance safety, support, and empowerment for survivors of intimate partner violence in the community. The intervention will consist of 9 weekly, 90-minute group sessions that will teach specific skills for identifying various forms of trauma and abuse, developing mutually supportive relationships, safety planning and self-care, goal-oriented communication, empowerment and self-efficacy, goal setting, coping, and connecting to resources. The investigators will pilot test the intervention, including evaluating the process of implementation, including feasibility, acceptability/likeability, and safety, as well as evaluating outcomes of safety, support, and empowerment. Outcomes from the intervention will be compared to outcomes from a traditional domestic violence support group.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
9
Inclusion Criteria
  • Domestic Violence Service Provider client referred for support group services
Exclusion Criteria
  • Unable to provide informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention as Usual: Traditional Domestic Violence Support GroupTraditional Domestic Violence Support Group75-minute support group; 18-weeks; led by a domestic violence service provider counselor or advocate
Primary Outcome Measures
NameTimeMethod
Intervention acceptability/likability: Participant ratings of acceptability assessed using the Trauma-Informed Practices Scale (TIPS)18 weeks

Acceptability will be assessed using the Trauma-Informed Practices Scale (TIPS). TIPS is a 33-item self-report measure comprised of 6 subscales. This study will use 28 of the original 33 items representing 5 of the 6 subscales: agency, information, connection, strengths, and cultural responsiveness and inclusivity; the support for parenting subscale was excluded as the intervention is not designed specifically to support parents. Items are rated on a 0-3 Likert scale, and mean scores are computed for each subscale and overall scale. Scores range from 0-3, with higher scores representing perceived receipt of more trauma-informed services.

Intervention acceptability/likability: Participant ratings of group cohesion assessed using the Group Attitude Scale (GAS)up to week 18

Group cohesion will be assessed weekly by a modified version of the GAS. The 20 items are rated on a 1-5 Likert scale. A total score is computed by averaging the items. Scores range from 1-5, with higher scores indicating more group cohesion.

Change in support assessed using the Domestic Violence Resource Utilization (DVR) questionnaireBaseline, 9 weeks, 18 weeks

Change in support will be assessed using the DVR questionnaire. The 24 items represent various types of services/resources used, and a count variable (0-24) is computed to indicate the total number of different kinds of services/resources an individual use.

Change in social support assessed using the Medical Outcomes Study Social Support (MOS-SS) SurveyBaseline, 9 weeks, 18 weeks

Change in support will be assessed using the MOS-SS Survey. The 19 items are rated on a 5-point Likert scale. Mean scores are computed for each of the four subscales (emotional/informational support, tangible support, affectionate support, and positive social interaction), and a total summary score. Scores range from 1-5, with higher scores indicating greater levels of support.

Change in empowerment assessed using the Personal Progress Scale - Revised (PPS-R)Baseline, 9 weeks, 18 weeks

Change in empowerment will be assessed using the PPS-R. The 28 items are rated on a 7-point Likert scale, and a total score is computed by averaging the items; total scores range from 1-7, with higher scores indicating higher levels of empowerment.

Intervention acceptability/likability: Participant ratings of Working alliance assessed using the Session Rating Scale (SRS)up to week 18

Working alliance will be measured using an adapted version of the SRS. The SRS is a 4-item visual analog instrument. Each item is assessed using a 0-10 point scale. This measure will be modified for the participant to rate the working alliance with the peer co-facilitator and professional co-facilitator separately, for a total of 6 questions. A total score is computed by summing each item. Scores will range from 0-60, with an overall score of less than 56, or 9 on any item, indicating potential concerns in working alliance

Change in safety-related empowerment assessed using the Measure of Victim Empowerment Related to Safety (MOVERS) ScaleBaseline, 9 weeks, 18 weeks

Change in safety-related empowerment will be assessed using the Expectation of Support and Internal Tools subscales of the MOVERS Scale. Items are rated on a 1-5 Likert scale. Items corresponding to each subscale are averaged. Scores range from 1-5, with higher scores indicating higher levels of safety-related empowerment.

Secondary Outcome Measures
NameTimeMethod
Change in Wellbeing assessed using the Rosenberg Self-Esteem ScaleBaseline, 9 weeks, 18 weeks

Change in Wellbeing will be assessed using the Rosenberg Self-Esteem Scale. The 10-item scale ranges from 0-30. Scores between 15 and 25 are within normal range; scores below 15 suggest low self-esteem.

Change in Wellbeing assessed using the Quality of Life questionnaireBaseline, 9 weeks, 18 weeks

Change in Wellbeing will be assessed using the Quality of Life questionnaire. The 9 items are rated on a 7-point Likert scale, and a total score is computed by averaging the items; total scores range from 1-7, with higher scores indicating higher levels of wellbeing.

Trial Locations

Locations (1)

Yale University

🇺🇸

New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath